134 related articles for article (PubMed ID: 35144219)
1. Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.
Cai C; Peng Y; Shen E; Wan R; Gao L; Gao Y; Zhou Y; Huang Q; Chen Y; Liu P; Guo C; Feng Z; Zhang X; Liu Y; Shen H; Zeng S; Han Y
EBioMedicine; 2022 Feb; 76():103866. PubMed ID: 35144219
[TBL] [Abstract][Full Text] [Related]
2. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
3. Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma.
Wan R; Bai L; Cai C; Ya W; Jiang J; Hu C; Chen Q; Zhao B; Li Y
Comput Struct Biotechnol J; 2021; 19():6386-6399. PubMed ID: 34938414
[TBL] [Abstract][Full Text] [Related]
4. GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma.
Wang J; Wang Y; Zhou J; Cai M; Guo P; Du T; Zhang H
J Cell Mol Med; 2023 Sep; 27(17):2517-2532. PubMed ID: 37448185
[TBL] [Abstract][Full Text] [Related]
5. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
[TBL] [Abstract][Full Text] [Related]
6. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
7. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X
Front Immunol; 2021; 12():725223. PubMed ID: 34484235
[TBL] [Abstract][Full Text] [Related]
8. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
10. Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases.
Wu Y; Jia H; Zhou H; Liu X; Sun J; Zhou X; Zhao H
Scand J Immunol; 2022 Feb; 95(2):e13119. PubMed ID: 34796980
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
12. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
13. Characterization the prognosis role and effects of snoRNAs in melanoma patients.
Wang LY; Song JN; Chen YX; Zhu Y; Ren HL; Li QQ; Zhang SH
Exp Dermatol; 2024 Jan; 33(1):e14944. PubMed ID: 37772659
[TBL] [Abstract][Full Text] [Related]
14. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
Front Immunol; 2021; 12():691811. PubMed ID: 34489938
[TBL] [Abstract][Full Text] [Related]
15. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
17. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of small nucleolar RNAs (snoRNAs) for colon adenocarcinoma based on RNA sequencing data.
Huang L; Liang XZ; Deng Y; Liang YB; Zhu X; Liang XY; Luo DZ; Chen G; Fang YY; Lan HH; Zeng JH
Pathol Res Pract; 2020 Jun; 216(6):152937. PubMed ID: 32312483
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis.
Zhou J; Guo H; Liu L; Feng M; Yang X; Hao S
Aging (Albany NY); 2022 Sep; 14(18):7547-7567. PubMed ID: 36152052
[TBL] [Abstract][Full Text] [Related]
20. A Prognostic Model of Colon Cancer Based on the Microenvironment Component Score
Liu Y; Liu X; Xu Q; Gao X; Linghu E
In Vivo; 2022; 36(2):753-763. PubMed ID: 35241531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
